Reactivity considerations in the analysis of glucuronide and sulfate conjugates of diflunisal

Therapeutic Drug Monitoring

Volumn 11, Issue 6, 1989, Pages 712-720

  Dickinson, Ronald G ^a   King, Andrew R ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Acyl migration; Diflunisal conjugation; Glucuronides; Sulfates

Indexed keywords

DIFLUNISAL; DRUG METABOLITE;

ANIMAL CELL; DRUG DETERMINATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMAL; BILE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIFLUNISAL; HYDROGEN-ION CONCENTRATION; HYDROLYSIS; MALE; METHANOL; RATS; RATS, INBRED STRAINS; SUPPORT, NON-U.S. GOV'T;

EID: 0024450037     PISSN: 01634356     EISSN: 15363694     Source Type: Journal    
DOI: 10.1097/00007691-198911000-00018     Document Type: Article

References (27)

1. Upton RA, Buskin JN, Williams RL, Holford NHG, Riegel-man S. Negligible excretion of unchanged ketoprofen, naproxen, and probenecid in urine. J Pharm Sci 1980; 69:1254-1257.
2. Faed EM. Properties of acyl glucuronides: implications for studies of the pharmacokinetics and metabolism of acidic drugs. Drug Metab Rev 1984;15:1213-1249.
3. Tocco DJ, Breault GO, Zacchei AG, Steelman SL, Perrier CV. Physiological disposition and metabolism of 5-(2',4'-difluorophenyl)salicylic acid, a new salicylate. Drug Metab Dispos 1975;3:453-466.
4. Loewen GR, McKay G, Verbeeck RK. Isolation and identification of a new major metabolite of diflunisal in man. The sulfate conjugate. Drug Metab Dispos 1986;14:127-31.
5. Ray JE, Day RO. High-performance liquid chromatographic analysis of diflunisal in plasma and urine: application to pharmacokinetic studies in two normal volunteers. J Pharm Sci 1983;72:1403-1405.
6. Veenendaal JR, MefFin PJ. Direct analysis of diflunisal ester and ether glucuronides by high-performance liquid chromatography. J Chromatogr 1984;307:432-438.
7. Musson DG, Lin JH, Lyon KA, Tocco DJ, Yeh KC. Assay methodology for quantification of the ester and ether gluc-uronide conjugates of diflunisal in human urine. J Chromatogr 1985;337:363-378.
8. Schwarz M, Chiou R, Stubbs RJ, Bayne WF. Determination of diflunisal in human plasma and urine by fast high-performance liquid chromatography. J Chromatogr 1986; 380:420-424.
9. Hansen-Moller J, Dalgaard L, Hansen SH. Reversed-phase high-performance liquid chromatographic assay for the simultaneous determination of diflunisal and its glucuronides in serum and urine. Rearrangement of the 1-O-acylgluc-uronide. J Chromatogr 1987;420:99-109.
10. Lin JH, Yeh KC, Duggan DE. Effect of enterohepatic circulation on the pharmacokinetics of diflunisal in rats. Drug Metab Dispos 1985;13:321-326.
11. Dickinson RG, King AR, Verbeeck RK. Elimination of diflunisal and its conjugates in the bile-exteriorized rat. Clin Exp Pharmacol Physiol 1987;suppl 1 1:84.
12. Eriksson L-O, Wahlin-Boll E, Odar-Cederlof I, Lindholm L, Melander A. Influence of renal failure, rheumatoid arthritis and old age on the pharmacokinetics of diflunisal. EurJ Clin Pharmacol 1989;36:165-174.
13. Cham BE, Bochner F, Imhoff DM, Johns D, Rowland M. Simultaneous liquid-chromatographic quantitation of salicylic acid, salicyluric acid, and gentisic acid in urine. Clin Chem 1980;26:111-114.
14. Hansen-Moller J, Cornett C, Dalgaard L, Hansen SH. Isolation and identification of the rearrangement products of diflunisal l-O-acyl glucuronide. J Pharm Biomed Anal1988;6:229-240.
15. Hasegawa J, Smith PC, Benet LZ. Apparent intramolecular acyl migration of zomepirac glucuronide. Drug Metab Dispos 1982;10:469-473.
16. Dickinson RG, Hooper WD, Eadie MJ. pH-dependent rearrangement of the biosynthetic ester glucuronide of valproic acid to 3-glucuronidase-resistant forms. Drug Metab Dispos1984;12:247-252.
17. Rachmel A, Hazleton GA, Yergey AL, Liberato DJ. Furo-semide l-O-acyl glucuronide. In vitro biosynthesis and pH-dependent isomerisation to 3-glucuronidase-resistant forms. Drug Metab Dispos 1985;13:705-710.
18. Dickinson RG, Kluck RM, Eadie MJ, Hooper WD. Disposition of 3-glucuronidase-resistant “glucuronides” of valproic acid after intrabiliary administration in the rat: intact absorption, fecal excretion and intestinal hydrolysis. J Pharmacol Exp Ther 1985;233:214-221.
19. Smith PC, Benet LZ. Characterization of the isomeric esters of zomepirac glucuronide by proton NMR. Drug Metab Dispos 1986;14:503-505.
20. Salmon M, Fenselau C, Cukier JO, Odell GB. Rapid transesterification of bilirubin glucuronides in methanol. Life Sci1974;15:2069-2078.
21. Smith PC, Hasegawa J, Langendijk PNJ, Benet LZ. Stability of acyl glucuronides in blood, plasma, and urine: studies with zomepirac. Drug Metab Dispos 1985;13:110-112.
22. Roy AB. The chemistry of sulfate esters and related compounds. In: Mulder GJ, ed. Sulfation of drugs and related compounds. Boca Raton, FL: CRC Press, 1981:5-30.
23. Loewen GR, Herman RJ, Ross SG, Verbeeck RK. Effect of dose on the glucuronidation and sulphation kinetics of diflunisal in man: single dose studies. Br J Clin Pharmacol1988;26:31-39.
24. Lin JH, Hooke KF, Yeh KC, Duggan DE. Dose-dependent pharmacokinetics of diflunisal in rats: dual effects of protein binding and metabolism. J Pharmacol Exp Ther 1985;235: 402-406.
25. Lin JH, Ulm EH, Duggan DE. Possible mechanisms for reduced plasma clearance of diflunisal in rat experimental renal failure. J Pharmacol Exp Ther 1986;238:978-984.
26. Lin JH, Chen I-W, Ulm EH, Duggan DE. Differential effects of phénobarbital on ester and ether glucuronidation of diflunisal in rats. J Pharmacol Exp Ther 1987;242:1013-1018.
27. Verbeeck RK, Dickinson RG, Pond SM. Biliary excretion of diflunisal conjugates in patients with T-tube drainage. Eur J Clin Pharmacol 1988;34:423-426.